Han Young Chung | Pathogenic Microbiology | Best Researcher Award Posted on 07/10/202407/10/2024 by ScienceFather Prof. Han Young Chung | Pathogenic Microbiology | Best Researcher Award Associate Professor at Chungnam National University/College of Pharmacy, South Korea Dr. Han Young Chung is an accomplished Assistant Professor at the College of Pharmacy, Chungnam National University, South Korea. With a Ph.D. in Molecular Microbiology and Toxicology from Seoul National University, Dr. Chung has an extensive background in gastroenterology research, having completed post-doctoral fellowships at The University of Michigan and Seoul National University. He has received multiple honors, including the Best Presentation Award from the Korean Society for Microbiology and Biotechnology and several prestigious scholarships. Dr. Chung has successfully secured research funding, notably leading a Creative Challenge Project funded by the National Research Foundation of Korea. His prolific publication record includes numerous articles in high-impact journals, focusing on food safety and pathogenic microorganisms. He has also presented his research internationally, contributing to advancements in understanding microbial interactions and pathogenesis. Dr. Chung’s dedication to research and teaching makes him a strong candidate for the Best Researcher Award. Profile Google Scholar Profile Education Dr. Han Young Chung has an impressive educational background that underpins his expertise in the field of molecular microbiology and toxicology. He completed his Bachelor’s degree in Biotechnology and Bioinformatics, graduating cum laude from Korea University in 2013, where he achieved an overall GPA of 4.4/4.5. Following this, he pursued his Ph.D. at Seoul National University, where he specialized in Molecular Microbiology and Toxicology. Dr. Chung excelled in his studies, earning a remarkable overall GPA of 4.11/4.3 while completing 60 credits from September 2013 to August 2020. After obtaining his doctorate, he enhanced his research experience as a Post-Doctoral Fellow at the University of Michigan Medical School from September 2022 to February 2024 and previously at the Center for Food and Bioconvergence at Seoul National University. His educational journey reflects a strong foundation in scientific research and dedication to advancing knowledge in his field. Professional Experience Dr. Han Young Chung is currently serving as an Assistant Professor at the College of Pharmacy, Chungnam National University in South Korea since March 2024. Prior to this role, he was a Post-Doctoral Fellow in the Division of Gastroenterology at the University of Michigan Medical School from September 2022 to February 2024. Dr. Chung also held the position of Research Assistant Professor at the Center for Food and Bioconvergence, Seoul National University (SNU), from June 2021 to August 2022, after completing another Post-Doctoral Fellowship at SNU from September 2020 to May 2021. His academic journey began with a Ph.D. in Molecular Microbiology and Toxicology from SNU (2013-2020) and a Bachelor’s degree in Biotechnology and Bioinformatics from Korea University (2009-2013). Throughout his career, Dr. Chung has contributed significantly to the fields of microbiology and toxicology, demonstrating a strong commitment to research and education. Research Interest Dr. Han Young Chung’s research interests lie at the intersection of molecular microbiology and toxicology, with a strong focus on food safety and pathogen virulence. His work explores the interactions between foodborne pathogens, such as Vibrio vulnificus and Staphylococcus aureus, and their impact on human health, particularly in relation to thrombosis and other adverse health outcomes. Dr. Chung employs advanced genomic and transcriptomic analyses to investigate the pathogenic mechanisms of these microbes, aiming to uncover insights that could enhance food safety measures. Additionally, he is interested in the role of nanomaterials, such as nanoplastics, in promoting coagulation and thrombus formation, which can have significant implications for public health. His interdisciplinary approach combines microbiology, toxicology, and bioinformatics, positioning him as a leader in research that addresses pressing issues in food safety and microbial pathogenesis. Research Skills Dr. Han Young Chung possesses a diverse and robust skill set in research, primarily focusing on molecular microbiology and toxicology. His expertise includes advanced techniques in genome and transcriptome analysis, enabling him to investigate the genetic makeup and pathogenicity of various microorganisms, particularly food-borne pathogens. He has significant experience in experimental design, data analysis, and interpretation, which he has demonstrated through numerous high-impact publications in reputable SCI journals. Dr. Chung is proficient in conducting in vitro and in vivo studies, utilizing cutting-edge methodologies such as nanotechnology and high-throughput sequencing. His ability to collaborate effectively with interdisciplinary teams has led to successful projects, including significant grants and innovative research initiatives. Furthermore, Dr. Chung’s strong presentation skills have enabled him to share his findings at international conferences, enhancing the visibility of his research and contributing to the global scientific community. Overall, his comprehensive research skills make him a valuable asset in the field. Award and Recognition Dr. Han Young Chung is a distinguished researcher currently serving as an Assistant Professor at the College of Pharmacy, Chungnam National University, South Korea. He holds a Ph.D. in Molecular Microbiology and Toxicology from Seoul National University and has completed post-doctoral fellowships at The University of Michigan Medical School and Seoul National University. Dr. Chung has received several honors, including the Best Presentation Award from the Korean Society for Microbiology and Biotechnology and the Best Performance Award during his undergraduate research program at Hanyang University. His research, which focuses on the pathogenesis of foodborne pathogens, has led to significant publications in high-impact journals, including Nature Communications and Particulate Science and Technology. Dr. Chung’s work has been supported by grants such as the National Research Foundation of Korea, underscoring his contribution to advancing scientific knowledge in his field. His innovative research and dedication make him a strong candidate for the Best Researcher Award. Conclusion Dr. Han Young Chung exemplifies the qualities of a leading researcher through his robust academic background, significant research contributions, and recognition in his field. His expertise in molecular microbiology and toxicology addresses critical issues in food safety and public health, making him a deserving candidate for the Best Researcher Award. By focusing on broader collaboration, mentorship, and public engagement, he can further enhance his impact in the scientific community and beyond. Recognizing his achievements with this award will not only honor his contributions but also inspire future researchers in the field. Publication Top Notes Loss of integrity: impairment of the blood-brain barrier in heavy metal-associated ischemic stroke Authors: JH Kim, HM Byun, EC Chung, HY Chung, ON Bae Year: 2013 Journal: Toxicological Research Volume/Issue/Page: 29, 157-164 Analysis of microbiota on abalone (Haliotis discus hannai) in South Korea for improved product management Authors: MJ Lee, JJ Lee, HY Chung, SH Choi, BS Kim Year: 2016 Journal: International Journal of Food Microbiology Volume/Issue/Page: 234, 45-52 Molecular interaction between methicillin-resistant Staphylococcus aureus (MRSA) and chicken breast reveals enhancement of pathogenesis and toxicity for food-borne outbreak Authors: HY Chung, YT Kim, JG Kwon, HH Im, D Ko, JH Lee, SH Choi Year: 2021 Journal: Food Microbiology Volume/Issue/Page: 93, 103602 Rapid, simultaneous and nanomolar determination of pyroglutamic acid and cis-/trans-urocanic acid in human stratum corneum by hydrophilic interaction liquid chromatography … Authors: KM Joo, JY Han, ED Son, GW Nam, HY Chung, HJ Jeong, JC Cho, … Year: 2012 Journal: Journal of Chromatography B Volume/Issue/Page: 897, 55-63 Amine-modified nanoplastics promote the procoagulant activation of isolated human red blood cells and thrombus formation in rats Authors: EH Kim, S Choi, D Kim, HJ Park, Y Bian, SH Choi, HY Chung, ON Bae Year: 2022 Journal: Particle and Fibre Toxicology Volume/Issue/Page: 19(1), 60 Titanium dioxide nanoparticles enhance thrombosis through triggering the phosphatidylserine exposure and procoagulant activation of red blood cells Authors: Y Bian, HY Chung, ON Bae, KM Lim, JH Chung, J Pi Year: 2021 Journal: Particle and Fibre Toxicology Volume/Issue/Page: 18, 1-12 Inhibitory effects of black soybean on platelet activation mediated through its active component of adenosine Authors: K Kim, KM Lim, HJ Shin, DB Seo, JY Noh, S Kang, HY Chung, S Shin, … Year: 2013 Journal: Thrombosis Research Volume/Issue/Page: 131(3), 254-261 Complete genome sequence of Vibrio vulnificus FORC_017 isolated from a patient with a hemorrhagic rash after consuming raw dotted gizzard shad Authors: HY Chung, YT Kim, S Kim, EJ Na, HJ Ku, KH Lee, ST Heo, S Ryu, H Kim, … Year: 2016 Journal: Gut Pathogens Volume/Issue/Page: 8, 1-6 Complete genome of Vibrio parahaemolyticus FORC014 isolated from the toothfish Authors: S Ahn, HY Chung, S Lim, K Kim, S Kim, EJ Na, K Caetano-Anolles, … Year: 2016 Journal: Gut Pathogens Volume/Issue/Page: 8, 1-6 Comparative genomic analysis reveals genetic features related to the virulence of Bacillus cereus FORC_013 Authors: HJ Koo, S Ahn, HY Chung, S Kim, K Kim, S Ryu, JH Lee, SH Choi, H Kim Year: 2017 Journal: Gut Pathogens Volume/Issue/Page: 9, 1-8
Dr. Han Young Chung is currently serving as an Assistant Professor at the College of Pharmacy, Chungnam National University in South Korea since March 2024. Prior to this role, he was a Post-Doctoral Fellow in the Division of Gastroenterology at the University of Michigan Medical School from September 2022 to February 2024. Dr. Chung also held the position of Research Assistant Professor at the Center for Food and Bioconvergence, Seoul National University (SNU), from June 2021 to August 2022, after completing another Post-Doctoral Fellowship at SNU from September 2020 to May 2021. His academic journey began with a Ph.D. in Molecular Microbiology and Toxicology from SNU (2013-2020) and a Bachelor’s degree in Biotechnology and Bioinformatics from Korea University (2009-2013). Throughout his career, Dr. Chung has contributed significantly to the fields of microbiology and toxicology, demonstrating a strong commitment to research and education. Research Interest Dr. Han Young Chung’s research interests lie at the intersection of molecular microbiology and toxicology, with a strong focus on food safety and pathogen virulence. His work explores the interactions between foodborne pathogens, such as Vibrio vulnificus and Staphylococcus aureus, and their impact on human health, particularly in relation to thrombosis and other adverse health outcomes. Dr. Chung employs advanced genomic and transcriptomic analyses to investigate the pathogenic mechanisms of these microbes, aiming to uncover insights that could enhance food safety measures. Additionally, he is interested in the role of nanomaterials, such as nanoplastics, in promoting coagulation and thrombus formation, which can have significant implications for public health. His interdisciplinary approach combines microbiology, toxicology, and bioinformatics, positioning him as a leader in research that addresses pressing issues in food safety and microbial pathogenesis. Research Skills Dr. Han Young Chung possesses a diverse and robust skill set in research, primarily focusing on molecular microbiology and toxicology. His expertise includes advanced techniques in genome and transcriptome analysis, enabling him to investigate the genetic makeup and pathogenicity of various microorganisms, particularly food-borne pathogens. He has significant experience in experimental design, data analysis, and interpretation, which he has demonstrated through numerous high-impact publications in reputable SCI journals. Dr. Chung is proficient in conducting in vitro and in vivo studies, utilizing cutting-edge methodologies such as nanotechnology and high-throughput sequencing. His ability to collaborate effectively with interdisciplinary teams has led to successful projects, including significant grants and innovative research initiatives. Furthermore, Dr. Chung’s strong presentation skills have enabled him to share his findings at international conferences, enhancing the visibility of his research and contributing to the global scientific community. Overall, his comprehensive research skills make him a valuable asset in the field. Award and Recognition Dr. Han Young Chung is a distinguished researcher currently serving as an Assistant Professor at the College of Pharmacy, Chungnam National University, South Korea. He holds a Ph.D. in Molecular Microbiology and Toxicology from Seoul National University and has completed post-doctoral fellowships at The University of Michigan Medical School and Seoul National University. Dr. Chung has received several honors, including the Best Presentation Award from the Korean Society for Microbiology and Biotechnology and the Best Performance Award during his undergraduate research program at Hanyang University. His research, which focuses on the pathogenesis of foodborne pathogens, has led to significant publications in high-impact journals, including Nature Communications and Particulate Science and Technology. Dr. Chung’s work has been supported by grants such as the National Research Foundation of Korea, underscoring his contribution to advancing scientific knowledge in his field. His innovative research and dedication make him a strong candidate for the Best Researcher Award. Conclusion Dr. Han Young Chung exemplifies the qualities of a leading researcher through his robust academic background, significant research contributions, and recognition in his field. His expertise in molecular microbiology and toxicology addresses critical issues in food safety and public health, making him a deserving candidate for the Best Researcher Award. By focusing on broader collaboration, mentorship, and public engagement, he can further enhance his impact in the scientific community and beyond. Recognizing his achievements with this award will not only honor his contributions but also inspire future researchers in the field. Publication Top Notes Loss of integrity: impairment of the blood-brain barrier in heavy metal-associated ischemic stroke Authors: JH Kim, HM Byun, EC Chung, HY Chung, ON Bae Year: 2013 Journal: Toxicological Research Volume/Issue/Page: 29, 157-164 Analysis of microbiota on abalone (Haliotis discus hannai) in South Korea for improved product management Authors: MJ Lee, JJ Lee, HY Chung, SH Choi, BS Kim Year: 2016 Journal: International Journal of Food Microbiology Volume/Issue/Page: 234, 45-52 Molecular interaction between methicillin-resistant Staphylococcus aureus (MRSA) and chicken breast reveals enhancement of pathogenesis and toxicity for food-borne outbreak Authors: HY Chung, YT Kim, JG Kwon, HH Im, D Ko, JH Lee, SH Choi Year: 2021 Journal: Food Microbiology Volume/Issue/Page: 93, 103602 Rapid, simultaneous and nanomolar determination of pyroglutamic acid and cis-/trans-urocanic acid in human stratum corneum by hydrophilic interaction liquid chromatography … Authors: KM Joo, JY Han, ED Son, GW Nam, HY Chung, HJ Jeong, JC Cho, … Year: 2012 Journal: Journal of Chromatography B Volume/Issue/Page: 897, 55-63 Amine-modified nanoplastics promote the procoagulant activation of isolated human red blood cells and thrombus formation in rats Authors: EH Kim, S Choi, D Kim, HJ Park, Y Bian, SH Choi, HY Chung, ON Bae Year: 2022 Journal: Particle and Fibre Toxicology Volume/Issue/Page: 19(1), 60 Titanium dioxide nanoparticles enhance thrombosis through triggering the phosphatidylserine exposure and procoagulant activation of red blood cells Authors: Y Bian, HY Chung, ON Bae, KM Lim, JH Chung, J Pi Year: 2021 Journal: Particle and Fibre Toxicology Volume/Issue/Page: 18, 1-12 Inhibitory effects of black soybean on platelet activation mediated through its active component of adenosine Authors: K Kim, KM Lim, HJ Shin, DB Seo, JY Noh, S Kang, HY Chung, S Shin, … Year: 2013 Journal: Thrombosis Research Volume/Issue/Page: 131(3), 254-261 Complete genome sequence of Vibrio vulnificus FORC_017 isolated from a patient with a hemorrhagic rash after consuming raw dotted gizzard shad Authors: HY Chung, YT Kim, S Kim, EJ Na, HJ Ku, KH Lee, ST Heo, S Ryu, H Kim, … Year: 2016 Journal: Gut Pathogens Volume/Issue/Page: 8, 1-6 Complete genome of Vibrio parahaemolyticus FORC014 isolated from the toothfish Authors: S Ahn, HY Chung, S Lim, K Kim, S Kim, EJ Na, K Caetano-Anolles, … Year: 2016 Journal: Gut Pathogens Volume/Issue/Page: 8, 1-6 Comparative genomic analysis reveals genetic features related to the virulence of Bacillus cereus FORC_013 Authors: HJ Koo, S Ahn, HY Chung, S Kim, K Kim, S Ryu, JH Lee, SH Choi, H Kim Year: 2017 Journal: Gut Pathogens Volume/Issue/Page: 9, 1-8
Dr. Han Young Chung is currently serving as an Assistant Professor at the College of Pharmacy, Chungnam National University in South Korea since March 2024. Prior to this role, he was a Post-Doctoral Fellow in the Division of Gastroenterology at the University of Michigan Medical School from September 2022 to February 2024. Dr. Chung also held the position of Research Assistant Professor at the Center for Food and Bioconvergence, Seoul National University (SNU), from June 2021 to August 2022, after completing another Post-Doctoral Fellowship at SNU from September 2020 to May 2021. His academic journey began with a Ph.D. in Molecular Microbiology and Toxicology from SNU (2013-2020) and a Bachelor’s degree in Biotechnology and Bioinformatics from Korea University (2009-2013). Throughout his career, Dr. Chung has contributed significantly to the fields of microbiology and toxicology, demonstrating a strong commitment to research and education.
Dr. Han Young Chung’s research interests lie at the intersection of molecular microbiology and toxicology, with a strong focus on food safety and pathogen virulence. His work explores the interactions between foodborne pathogens, such as Vibrio vulnificus and Staphylococcus aureus, and their impact on human health, particularly in relation to thrombosis and other adverse health outcomes. Dr. Chung employs advanced genomic and transcriptomic analyses to investigate the pathogenic mechanisms of these microbes, aiming to uncover insights that could enhance food safety measures. Additionally, he is interested in the role of nanomaterials, such as nanoplastics, in promoting coagulation and thrombus formation, which can have significant implications for public health. His interdisciplinary approach combines microbiology, toxicology, and bioinformatics, positioning him as a leader in research that addresses pressing issues in food safety and microbial pathogenesis. Research Skills Dr. Han Young Chung possesses a diverse and robust skill set in research, primarily focusing on molecular microbiology and toxicology. His expertise includes advanced techniques in genome and transcriptome analysis, enabling him to investigate the genetic makeup and pathogenicity of various microorganisms, particularly food-borne pathogens. He has significant experience in experimental design, data analysis, and interpretation, which he has demonstrated through numerous high-impact publications in reputable SCI journals. Dr. Chung is proficient in conducting in vitro and in vivo studies, utilizing cutting-edge methodologies such as nanotechnology and high-throughput sequencing. His ability to collaborate effectively with interdisciplinary teams has led to successful projects, including significant grants and innovative research initiatives. Furthermore, Dr. Chung’s strong presentation skills have enabled him to share his findings at international conferences, enhancing the visibility of his research and contributing to the global scientific community. Overall, his comprehensive research skills make him a valuable asset in the field. Award and Recognition Dr. Han Young Chung is a distinguished researcher currently serving as an Assistant Professor at the College of Pharmacy, Chungnam National University, South Korea. He holds a Ph.D. in Molecular Microbiology and Toxicology from Seoul National University and has completed post-doctoral fellowships at The University of Michigan Medical School and Seoul National University. Dr. Chung has received several honors, including the Best Presentation Award from the Korean Society for Microbiology and Biotechnology and the Best Performance Award during his undergraduate research program at Hanyang University. His research, which focuses on the pathogenesis of foodborne pathogens, has led to significant publications in high-impact journals, including Nature Communications and Particulate Science and Technology. Dr. Chung’s work has been supported by grants such as the National Research Foundation of Korea, underscoring his contribution to advancing scientific knowledge in his field. His innovative research and dedication make him a strong candidate for the Best Researcher Award. Conclusion Dr. Han Young Chung exemplifies the qualities of a leading researcher through his robust academic background, significant research contributions, and recognition in his field. His expertise in molecular microbiology and toxicology addresses critical issues in food safety and public health, making him a deserving candidate for the Best Researcher Award. By focusing on broader collaboration, mentorship, and public engagement, he can further enhance his impact in the scientific community and beyond. Recognizing his achievements with this award will not only honor his contributions but also inspire future researchers in the field. Publication Top Notes Loss of integrity: impairment of the blood-brain barrier in heavy metal-associated ischemic stroke Authors: JH Kim, HM Byun, EC Chung, HY Chung, ON Bae Year: 2013 Journal: Toxicological Research Volume/Issue/Page: 29, 157-164 Analysis of microbiota on abalone (Haliotis discus hannai) in South Korea for improved product management Authors: MJ Lee, JJ Lee, HY Chung, SH Choi, BS Kim Year: 2016 Journal: International Journal of Food Microbiology Volume/Issue/Page: 234, 45-52 Molecular interaction between methicillin-resistant Staphylococcus aureus (MRSA) and chicken breast reveals enhancement of pathogenesis and toxicity for food-borne outbreak Authors: HY Chung, YT Kim, JG Kwon, HH Im, D Ko, JH Lee, SH Choi Year: 2021 Journal: Food Microbiology Volume/Issue/Page: 93, 103602 Rapid, simultaneous and nanomolar determination of pyroglutamic acid and cis-/trans-urocanic acid in human stratum corneum by hydrophilic interaction liquid chromatography … Authors: KM Joo, JY Han, ED Son, GW Nam, HY Chung, HJ Jeong, JC Cho, … Year: 2012 Journal: Journal of Chromatography B Volume/Issue/Page: 897, 55-63 Amine-modified nanoplastics promote the procoagulant activation of isolated human red blood cells and thrombus formation in rats Authors: EH Kim, S Choi, D Kim, HJ Park, Y Bian, SH Choi, HY Chung, ON Bae Year: 2022 Journal: Particle and Fibre Toxicology Volume/Issue/Page: 19(1), 60 Titanium dioxide nanoparticles enhance thrombosis through triggering the phosphatidylserine exposure and procoagulant activation of red blood cells Authors: Y Bian, HY Chung, ON Bae, KM Lim, JH Chung, J Pi Year: 2021 Journal: Particle and Fibre Toxicology Volume/Issue/Page: 18, 1-12 Inhibitory effects of black soybean on platelet activation mediated through its active component of adenosine Authors: K Kim, KM Lim, HJ Shin, DB Seo, JY Noh, S Kang, HY Chung, S Shin, … Year: 2013 Journal: Thrombosis Research Volume/Issue/Page: 131(3), 254-261 Complete genome sequence of Vibrio vulnificus FORC_017 isolated from a patient with a hemorrhagic rash after consuming raw dotted gizzard shad Authors: HY Chung, YT Kim, S Kim, EJ Na, HJ Ku, KH Lee, ST Heo, S Ryu, H Kim, … Year: 2016 Journal: Gut Pathogens Volume/Issue/Page: 8, 1-6 Complete genome of Vibrio parahaemolyticus FORC014 isolated from the toothfish Authors: S Ahn, HY Chung, S Lim, K Kim, S Kim, EJ Na, K Caetano-Anolles, … Year: 2016 Journal: Gut Pathogens Volume/Issue/Page: 8, 1-6 Comparative genomic analysis reveals genetic features related to the virulence of Bacillus cereus FORC_013 Authors: HJ Koo, S Ahn, HY Chung, S Kim, K Kim, S Ryu, JH Lee, SH Choi, H Kim Year: 2017 Journal: Gut Pathogens Volume/Issue/Page: 9, 1-8
Dr. Han Young Chung’s research interests lie at the intersection of molecular microbiology and toxicology, with a strong focus on food safety and pathogen virulence. His work explores the interactions between foodborne pathogens, such as Vibrio vulnificus and Staphylococcus aureus, and their impact on human health, particularly in relation to thrombosis and other adverse health outcomes. Dr. Chung employs advanced genomic and transcriptomic analyses to investigate the pathogenic mechanisms of these microbes, aiming to uncover insights that could enhance food safety measures. Additionally, he is interested in the role of nanomaterials, such as nanoplastics, in promoting coagulation and thrombus formation, which can have significant implications for public health. His interdisciplinary approach combines microbiology, toxicology, and bioinformatics, positioning him as a leader in research that addresses pressing issues in food safety and microbial pathogenesis. Research Skills Dr. Han Young Chung possesses a diverse and robust skill set in research, primarily focusing on molecular microbiology and toxicology. His expertise includes advanced techniques in genome and transcriptome analysis, enabling him to investigate the genetic makeup and pathogenicity of various microorganisms, particularly food-borne pathogens. He has significant experience in experimental design, data analysis, and interpretation, which he has demonstrated through numerous high-impact publications in reputable SCI journals. Dr. Chung is proficient in conducting in vitro and in vivo studies, utilizing cutting-edge methodologies such as nanotechnology and high-throughput sequencing. His ability to collaborate effectively with interdisciplinary teams has led to successful projects, including significant grants and innovative research initiatives. Furthermore, Dr. Chung’s strong presentation skills have enabled him to share his findings at international conferences, enhancing the visibility of his research and contributing to the global scientific community. Overall, his comprehensive research skills make him a valuable asset in the field. Award and Recognition Dr. Han Young Chung is a distinguished researcher currently serving as an Assistant Professor at the College of Pharmacy, Chungnam National University, South Korea. He holds a Ph.D. in Molecular Microbiology and Toxicology from Seoul National University and has completed post-doctoral fellowships at The University of Michigan Medical School and Seoul National University. Dr. Chung has received several honors, including the Best Presentation Award from the Korean Society for Microbiology and Biotechnology and the Best Performance Award during his undergraduate research program at Hanyang University. His research, which focuses on the pathogenesis of foodborne pathogens, has led to significant publications in high-impact journals, including Nature Communications and Particulate Science and Technology. Dr. Chung’s work has been supported by grants such as the National Research Foundation of Korea, underscoring his contribution to advancing scientific knowledge in his field. His innovative research and dedication make him a strong candidate for the Best Researcher Award. Conclusion Dr. Han Young Chung exemplifies the qualities of a leading researcher through his robust academic background, significant research contributions, and recognition in his field. His expertise in molecular microbiology and toxicology addresses critical issues in food safety and public health, making him a deserving candidate for the Best Researcher Award. By focusing on broader collaboration, mentorship, and public engagement, he can further enhance his impact in the scientific community and beyond. Recognizing his achievements with this award will not only honor his contributions but also inspire future researchers in the field. Publication Top Notes Loss of integrity: impairment of the blood-brain barrier in heavy metal-associated ischemic stroke Authors: JH Kim, HM Byun, EC Chung, HY Chung, ON Bae Year: 2013 Journal: Toxicological Research Volume/Issue/Page: 29, 157-164 Analysis of microbiota on abalone (Haliotis discus hannai) in South Korea for improved product management Authors: MJ Lee, JJ Lee, HY Chung, SH Choi, BS Kim Year: 2016 Journal: International Journal of Food Microbiology Volume/Issue/Page: 234, 45-52 Molecular interaction between methicillin-resistant Staphylococcus aureus (MRSA) and chicken breast reveals enhancement of pathogenesis and toxicity for food-borne outbreak Authors: HY Chung, YT Kim, JG Kwon, HH Im, D Ko, JH Lee, SH Choi Year: 2021 Journal: Food Microbiology Volume/Issue/Page: 93, 103602 Rapid, simultaneous and nanomolar determination of pyroglutamic acid and cis-/trans-urocanic acid in human stratum corneum by hydrophilic interaction liquid chromatography … Authors: KM Joo, JY Han, ED Son, GW Nam, HY Chung, HJ Jeong, JC Cho, … Year: 2012 Journal: Journal of Chromatography B Volume/Issue/Page: 897, 55-63 Amine-modified nanoplastics promote the procoagulant activation of isolated human red blood cells and thrombus formation in rats Authors: EH Kim, S Choi, D Kim, HJ Park, Y Bian, SH Choi, HY Chung, ON Bae Year: 2022 Journal: Particle and Fibre Toxicology Volume/Issue/Page: 19(1), 60 Titanium dioxide nanoparticles enhance thrombosis through triggering the phosphatidylserine exposure and procoagulant activation of red blood cells Authors: Y Bian, HY Chung, ON Bae, KM Lim, JH Chung, J Pi Year: 2021 Journal: Particle and Fibre Toxicology Volume/Issue/Page: 18, 1-12 Inhibitory effects of black soybean on platelet activation mediated through its active component of adenosine Authors: K Kim, KM Lim, HJ Shin, DB Seo, JY Noh, S Kang, HY Chung, S Shin, … Year: 2013 Journal: Thrombosis Research Volume/Issue/Page: 131(3), 254-261 Complete genome sequence of Vibrio vulnificus FORC_017 isolated from a patient with a hemorrhagic rash after consuming raw dotted gizzard shad Authors: HY Chung, YT Kim, S Kim, EJ Na, HJ Ku, KH Lee, ST Heo, S Ryu, H Kim, … Year: 2016 Journal: Gut Pathogens Volume/Issue/Page: 8, 1-6 Complete genome of Vibrio parahaemolyticus FORC014 isolated from the toothfish Authors: S Ahn, HY Chung, S Lim, K Kim, S Kim, EJ Na, K Caetano-Anolles, … Year: 2016 Journal: Gut Pathogens Volume/Issue/Page: 8, 1-6 Comparative genomic analysis reveals genetic features related to the virulence of Bacillus cereus FORC_013 Authors: HJ Koo, S Ahn, HY Chung, S Kim, K Kim, S Ryu, JH Lee, SH Choi, H Kim Year: 2017 Journal: Gut Pathogens Volume/Issue/Page: 9, 1-8
Dr. Han Young Chung’s research interests lie at the intersection of molecular microbiology and toxicology, with a strong focus on food safety and pathogen virulence. His work explores the interactions between foodborne pathogens, such as Vibrio vulnificus and Staphylococcus aureus, and their impact on human health, particularly in relation to thrombosis and other adverse health outcomes. Dr. Chung employs advanced genomic and transcriptomic analyses to investigate the pathogenic mechanisms of these microbes, aiming to uncover insights that could enhance food safety measures. Additionally, he is interested in the role of nanomaterials, such as nanoplastics, in promoting coagulation and thrombus formation, which can have significant implications for public health. His interdisciplinary approach combines microbiology, toxicology, and bioinformatics, positioning him as a leader in research that addresses pressing issues in food safety and microbial pathogenesis. Research Skills Dr. Han Young Chung possesses a diverse and robust skill set in research, primarily focusing on molecular microbiology and toxicology. His expertise includes advanced techniques in genome and transcriptome analysis, enabling him to investigate the genetic makeup and pathogenicity of various microorganisms, particularly food-borne pathogens. He has significant experience in experimental design, data analysis, and interpretation, which he has demonstrated through numerous high-impact publications in reputable SCI journals. Dr. Chung is proficient in conducting in vitro and in vivo studies, utilizing cutting-edge methodologies such as nanotechnology and high-throughput sequencing. His ability to collaborate effectively with interdisciplinary teams has led to successful projects, including significant grants and innovative research initiatives. Furthermore, Dr. Chung’s strong presentation skills have enabled him to share his findings at international conferences, enhancing the visibility of his research and contributing to the global scientific community. Overall, his comprehensive research skills make him a valuable asset in the field. Award and Recognition Dr. Han Young Chung is a distinguished researcher currently serving as an Assistant Professor at the College of Pharmacy, Chungnam National University, South Korea. He holds a Ph.D. in Molecular Microbiology and Toxicology from Seoul National University and has completed post-doctoral fellowships at The University of Michigan Medical School and Seoul National University. Dr. Chung has received several honors, including the Best Presentation Award from the Korean Society for Microbiology and Biotechnology and the Best Performance Award during his undergraduate research program at Hanyang University. His research, which focuses on the pathogenesis of foodborne pathogens, has led to significant publications in high-impact journals, including Nature Communications and Particulate Science and Technology. Dr. Chung’s work has been supported by grants such as the National Research Foundation of Korea, underscoring his contribution to advancing scientific knowledge in his field. His innovative research and dedication make him a strong candidate for the Best Researcher Award. Conclusion Dr. Han Young Chung exemplifies the qualities of a leading researcher through his robust academic background, significant research contributions, and recognition in his field. His expertise in molecular microbiology and toxicology addresses critical issues in food safety and public health, making him a deserving candidate for the Best Researcher Award. By focusing on broader collaboration, mentorship, and public engagement, he can further enhance his impact in the scientific community and beyond. Recognizing his achievements with this award will not only honor his contributions but also inspire future researchers in the field. Publication Top Notes Loss of integrity: impairment of the blood-brain barrier in heavy metal-associated ischemic stroke Authors: JH Kim, HM Byun, EC Chung, HY Chung, ON Bae Year: 2013 Journal: Toxicological Research Volume/Issue/Page: 29, 157-164 Analysis of microbiota on abalone (Haliotis discus hannai) in South Korea for improved product management Authors: MJ Lee, JJ Lee, HY Chung, SH Choi, BS Kim Year: 2016 Journal: International Journal of Food Microbiology Volume/Issue/Page: 234, 45-52 Molecular interaction between methicillin-resistant Staphylococcus aureus (MRSA) and chicken breast reveals enhancement of pathogenesis and toxicity for food-borne outbreak Authors: HY Chung, YT Kim, JG Kwon, HH Im, D Ko, JH Lee, SH Choi Year: 2021 Journal: Food Microbiology Volume/Issue/Page: 93, 103602 Rapid, simultaneous and nanomolar determination of pyroglutamic acid and cis-/trans-urocanic acid in human stratum corneum by hydrophilic interaction liquid chromatography … Authors: KM Joo, JY Han, ED Son, GW Nam, HY Chung, HJ Jeong, JC Cho, … Year: 2012 Journal: Journal of Chromatography B Volume/Issue/Page: 897, 55-63 Amine-modified nanoplastics promote the procoagulant activation of isolated human red blood cells and thrombus formation in rats Authors: EH Kim, S Choi, D Kim, HJ Park, Y Bian, SH Choi, HY Chung, ON Bae Year: 2022 Journal: Particle and Fibre Toxicology Volume/Issue/Page: 19(1), 60 Titanium dioxide nanoparticles enhance thrombosis through triggering the phosphatidylserine exposure and procoagulant activation of red blood cells Authors: Y Bian, HY Chung, ON Bae, KM Lim, JH Chung, J Pi Year: 2021 Journal: Particle and Fibre Toxicology Volume/Issue/Page: 18, 1-12 Inhibitory effects of black soybean on platelet activation mediated through its active component of adenosine Authors: K Kim, KM Lim, HJ Shin, DB Seo, JY Noh, S Kang, HY Chung, S Shin, … Year: 2013 Journal: Thrombosis Research Volume/Issue/Page: 131(3), 254-261 Complete genome sequence of Vibrio vulnificus FORC_017 isolated from a patient with a hemorrhagic rash after consuming raw dotted gizzard shad Authors: HY Chung, YT Kim, S Kim, EJ Na, HJ Ku, KH Lee, ST Heo, S Ryu, H Kim, … Year: 2016 Journal: Gut Pathogens Volume/Issue/Page: 8, 1-6 Complete genome of Vibrio parahaemolyticus FORC014 isolated from the toothfish Authors: S Ahn, HY Chung, S Lim, K Kim, S Kim, EJ Na, K Caetano-Anolles, … Year: 2016 Journal: Gut Pathogens Volume/Issue/Page: 8, 1-6 Comparative genomic analysis reveals genetic features related to the virulence of Bacillus cereus FORC_013 Authors: HJ Koo, S Ahn, HY Chung, S Kim, K Kim, S Ryu, JH Lee, SH Choi, H Kim Year: 2017 Journal: Gut Pathogens Volume/Issue/Page: 9, 1-8
Dr. Han Young Chung possesses a diverse and robust skill set in research, primarily focusing on molecular microbiology and toxicology. His expertise includes advanced techniques in genome and transcriptome analysis, enabling him to investigate the genetic makeup and pathogenicity of various microorganisms, particularly food-borne pathogens. He has significant experience in experimental design, data analysis, and interpretation, which he has demonstrated through numerous high-impact publications in reputable SCI journals. Dr. Chung is proficient in conducting in vitro and in vivo studies, utilizing cutting-edge methodologies such as nanotechnology and high-throughput sequencing. His ability to collaborate effectively with interdisciplinary teams has led to successful projects, including significant grants and innovative research initiatives. Furthermore, Dr. Chung’s strong presentation skills have enabled him to share his findings at international conferences, enhancing the visibility of his research and contributing to the global scientific community. Overall, his comprehensive research skills make him a valuable asset in the field. Award and Recognition
Dr. Han Young Chung possesses a diverse and robust skill set in research, primarily focusing on molecular microbiology and toxicology. His expertise includes advanced techniques in genome and transcriptome analysis, enabling him to investigate the genetic makeup and pathogenicity of various microorganisms, particularly food-borne pathogens. He has significant experience in experimental design, data analysis, and interpretation, which he has demonstrated through numerous high-impact publications in reputable SCI journals. Dr. Chung is proficient in conducting in vitro and in vivo studies, utilizing cutting-edge methodologies such as nanotechnology and high-throughput sequencing. His ability to collaborate effectively with interdisciplinary teams has led to successful projects, including significant grants and innovative research initiatives. Furthermore, Dr. Chung’s strong presentation skills have enabled him to share his findings at international conferences, enhancing the visibility of his research and contributing to the global scientific community. Overall, his comprehensive research skills make him a valuable asset in the field.
Francisco Boix Giner | Immunology and Microbiology | Best Researcher Award Posted on 29/08/202429/08/2024 by ScienceFather Dr. Francisco Boix Giner | Immunology and Microbiology | Best Researcher Award Clinical Immunologist, Blood Transfusion Center of the Valencian Community, Spain Francisco José Boix Giner is a distinguished immunologist with a strong academic and professional background. Currently working at the Centro de Transfusión de la Comunidad Valenciana, he has a notable career in both clinical and research settings. Boix Giner’s expertise spans genomic characterization, immunogenetics, and biomarker validation, evidenced by his leadership in multiple research projects, including studies on leukemia, COVID-19, and organ transplantation. He earned his Ph.D. from the University of Murcia with a thesis on immunosuppressive treatment biomarkers. His professional experience includes roles at prestigious institutions such as the National Health Service Blood and Transplant and Anthony Nolan in the UK. With an h-index of 15 and substantial contributions to various research projects, Boix Giner’s work is highly regarded in the field of immunology. His research achievements reflect a deep commitment to advancing knowledge in immunogenetics and personalized medicine. Profile Scopus Profile ORCID Profile Education Francisco José Boix Giner holds a comprehensive academic background in biomedical sciences. He earned his undergraduate degree in Biological Sciences with a specialization in Biomedicine from the University of Alicante in Spain, graduating with honors in September 2006. He further pursued advanced studies by completing a Master’s degree in Biomedical Technology and Research at the University of Murcia in September 2010, where he achieved an outstanding grade. Francisco then obtained his Ph.D. from the University of Murcia in June 2017, with a thesis focused on validating biomarkers for transplant patients undergoing immunosuppressive treatment. His doctoral work was conducted under the guidance of Manuel Muro Amador and Rocío Álvarez López, and it was awarded the highest distinction of “Sobresaliente Cum Laude.” This rigorous educational foundation has significantly contributed to his expertise and research in immunology and biomolecular sciences. Professional Experience Francisco José Boix Giner has accumulated extensive experience in immunology across several prestigious institutions. He currently serves as a Specialist in Immunology at the Centro de Transfusión de la Comunidad Valenciana, where he has been employed since November 2021. Previously, Boix held similar roles at the Hospital Universitario de Salamanca from June 2018 to November 2021, the National Health Service Blood and Transplant, and the Anthony Nolan Foundation in the UK, from 2013 to 2018. His career began at the Hospital Universitario Virgen de La Arrixaca, where he completed his residency in immunology. Boix’s work has involved leading and contributing to significant research projects, including genomic characterization of leukemia and studies on COVID-19 immunogenetics. His professional journey reflects a robust expertise in both clinical and research settings within the field of immunology. Research Interest Francisco José Boix Giner’s research interests center around immunology, with a particular focus on the genetic and molecular mechanisms underlying immune responses and transplant outcomes. His work includes characterizing genetic variations associated with immune system functions, such as the role of HLA and KIR genes in disease susceptibility and treatment responses. He has been involved in projects studying the impact of genetic markers on the resistance and relapse of leukemia, as well as the immunogenetic factors influencing COVID-19 prognosis. His research also extends to exploring biomarkers for assessing individual responses to immunosuppressive treatments in organ transplant patients. Boix Giner’s contributions aim to enhance the understanding of immune system interactions, improve diagnostic and therapeutic strategies, and advance personalized medicine in immunology and transplant science. Research Skills Francisco José Boix Giner possesses extensive research skills in the field of immunology and biomedicine. His expertise spans across various critical areas, including the characterization of genomic mechanisms in high-risk leukemia, the impact of HLA system on SARS-CoV-2 infections, and the identification of immune genetic variations in COVID-19 patients. Boix Giner has a proven track record in coordinating and leading significant research projects, such as those focused on biomarkers for preeclampsia and uterine growth restriction, as well as haplotypic characterization in leukemia patients. His proficiency in advanced techniques, including next-generation sequencing (NGS) and single-cell analysis, is complemented by his ability to secure and manage substantial research funding. His role in high-impact projects and collaborations with esteemed institutions highlights his skill in translating complex scientific data into actionable insights, furthering advancements in immunological research and patient care. Award and Recognition Francisco José Boix Giner, an esteemed immunologist, has garnered notable recognition in his field through a series of distinguished awards and accolades. He has been acknowledged for his significant contributions to the field of immunology, particularly in genomics and biomarker research. Boix Giner’s exceptional work has been recognized with multiple awards, including those for his innovative research on immune responses and transplantation. His research on the characterization of genomic mechanisms in leukemia and the validation of biomarkers in transplantation has earned him commendations from various institutions. In addition, he has received accolades for his leadership in high-impact research projects and his contributions to advancing understanding in immunogenetics and biomedicine. Boix Giner’s accolades underscore his commitment to scientific excellence and his influential role in the advancement of immunological research. Conclusion Francisco José Boix Giner is a well-qualified candidate for the Research for Best Researcher Award due to his extensive experience, significant contributions to immunology research, and strong academic background. To further strengthen his candidacy, focusing on increasing high-impact publications, expanding his research scope, and enhancing public engagement could be beneficial. Overall, his achievements and expertise make him a compelling candidate for the award. Publication Top Notes Killer-cell immunoglobulin-like receptor polymorphism is associated with COVID-19 outcome: Results of a pilot observational study Authors: Niño-Ramírez, J.E., Alcoceba, M., Gutiérrez-Zufiaurre, M.N., García-Sanz, R., Boix, F. Year: 2024 Journal: HLA CD8+CD69+ and CD8+CD95+ Mediate Early Post-Transplant Acute Tubular Injury in Kidney Recipients Authors: Boix, F., Jimenez-Coll, V., Legaz, I., Llorente, S., Muro, M. Year: 2023 Journal: Frontiers in Bioscience – Landmark Citations: 1 Monitoring of Serological, Cellular and Genomic Biomarkers in Transplantation, Computational Prediction Models and Role of Cell-Free DNA in Transplant Outcome Authors: Jimenez-Coll, V., Llorente, S., Boix, F., Legaz, I., Muro, M. Year: 2023 Journal: International Journal of Molecular Sciences Citations: 5 Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy Authors: Bailén, R., Alenda, R., Herruzo-Delgado, B., Anguita, J., Kwon, M. Year: 2023 Journal: Frontiers in Immunology Citations: 4 Identification of the novel HLA-A*23:01:01:27 allele in an acute myeloid patient and related donor Authors: Bastos, M., Alcoceba, M., Chillón, M.C., García-Sanz, R., Boix, F. Year: 2022 Journal: HLA Citations: 2 The age again in the eye of the COVID-19 storm: evidence-based decision making Authors: Martín, M.C., Jurado, A., Abad-Molina, C., Ocaña, E., Molina, J. Year: 2021 Journal: Immunity and Ageing Citations: 7 The novel HLA-DQB1*06:03:27 allele characterised by sequence-based typing in a European bone marrow donor Authors: Boix, F., Chillón, M.C., García-Sánchez, S., Alcoceba, M., Marín-Rubio, L.A. Year: 2021 Journal: HLA Citations: 2 Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome Authors: El Band, J.E.K., Llorente, S., Martinez-Garcia, P., Legaz, I., Muro, M. Year: 2021 Journal: Current Protein and Peptide Science Citations: 2 Allele and haplotype frequencies of HLA-A, -B, -C, -DRB1, -DQB1 and -DQA1 in Castile and Leon region from North West of Spain Authors: Boix, F., Marín-Rubio, L.A., Alcoceba, M., González, M., García-Sanz, R. Year: 2021 Journal: Human Immunology Citations: 1 Microrna expression changes in kidney transplant: Diagnostic efficacy of mir-150-5p as potential rejection biomarker, pilot study Authors: Alfaro, R., Legaz, I., Jimenez-Coll, V., Llorente, S., Muro, M. Year: 2021 Journal: Journal of Clinical Medicine Citations: 14
Francisco José Boix Giner is a distinguished immunologist with a strong academic and professional background. Currently working at the Centro de Transfusión de la Comunidad Valenciana, he has a notable career in both clinical and research settings. Boix Giner’s expertise spans genomic characterization, immunogenetics, and biomarker validation, evidenced by his leadership in multiple research projects, including studies on leukemia, COVID-19, and organ transplantation. He earned his Ph.D. from the University of Murcia with a thesis on immunosuppressive treatment biomarkers. His professional experience includes roles at prestigious institutions such as the National Health Service Blood and Transplant and Anthony Nolan in the UK. With an h-index of 15 and substantial contributions to various research projects, Boix Giner’s work is highly regarded in the field of immunology. His research achievements reflect a deep commitment to advancing knowledge in immunogenetics and personalized medicine. Profile Scopus Profile ORCID Profile Education Francisco José Boix Giner holds a comprehensive academic background in biomedical sciences. He earned his undergraduate degree in Biological Sciences with a specialization in Biomedicine from the University of Alicante in Spain, graduating with honors in September 2006. He further pursued advanced studies by completing a Master’s degree in Biomedical Technology and Research at the University of Murcia in September 2010, where he achieved an outstanding grade. Francisco then obtained his Ph.D. from the University of Murcia in June 2017, with a thesis focused on validating biomarkers for transplant patients undergoing immunosuppressive treatment. His doctoral work was conducted under the guidance of Manuel Muro Amador and Rocío Álvarez López, and it was awarded the highest distinction of “Sobresaliente Cum Laude.” This rigorous educational foundation has significantly contributed to his expertise and research in immunology and biomolecular sciences. Professional Experience Francisco José Boix Giner has accumulated extensive experience in immunology across several prestigious institutions. He currently serves as a Specialist in Immunology at the Centro de Transfusión de la Comunidad Valenciana, where he has been employed since November 2021. Previously, Boix held similar roles at the Hospital Universitario de Salamanca from June 2018 to November 2021, the National Health Service Blood and Transplant, and the Anthony Nolan Foundation in the UK, from 2013 to 2018. His career began at the Hospital Universitario Virgen de La Arrixaca, where he completed his residency in immunology. Boix’s work has involved leading and contributing to significant research projects, including genomic characterization of leukemia and studies on COVID-19 immunogenetics. His professional journey reflects a robust expertise in both clinical and research settings within the field of immunology. Research Interest Francisco José Boix Giner’s research interests center around immunology, with a particular focus on the genetic and molecular mechanisms underlying immune responses and transplant outcomes. His work includes characterizing genetic variations associated with immune system functions, such as the role of HLA and KIR genes in disease susceptibility and treatment responses. He has been involved in projects studying the impact of genetic markers on the resistance and relapse of leukemia, as well as the immunogenetic factors influencing COVID-19 prognosis. His research also extends to exploring biomarkers for assessing individual responses to immunosuppressive treatments in organ transplant patients. Boix Giner’s contributions aim to enhance the understanding of immune system interactions, improve diagnostic and therapeutic strategies, and advance personalized medicine in immunology and transplant science. Research Skills Francisco José Boix Giner possesses extensive research skills in the field of immunology and biomedicine. His expertise spans across various critical areas, including the characterization of genomic mechanisms in high-risk leukemia, the impact of HLA system on SARS-CoV-2 infections, and the identification of immune genetic variations in COVID-19 patients. Boix Giner has a proven track record in coordinating and leading significant research projects, such as those focused on biomarkers for preeclampsia and uterine growth restriction, as well as haplotypic characterization in leukemia patients. His proficiency in advanced techniques, including next-generation sequencing (NGS) and single-cell analysis, is complemented by his ability to secure and manage substantial research funding. His role in high-impact projects and collaborations with esteemed institutions highlights his skill in translating complex scientific data into actionable insights, furthering advancements in immunological research and patient care. Award and Recognition Francisco José Boix Giner, an esteemed immunologist, has garnered notable recognition in his field through a series of distinguished awards and accolades. He has been acknowledged for his significant contributions to the field of immunology, particularly in genomics and biomarker research. Boix Giner’s exceptional work has been recognized with multiple awards, including those for his innovative research on immune responses and transplantation. His research on the characterization of genomic mechanisms in leukemia and the validation of biomarkers in transplantation has earned him commendations from various institutions. In addition, he has received accolades for his leadership in high-impact research projects and his contributions to advancing understanding in immunogenetics and biomedicine. Boix Giner’s accolades underscore his commitment to scientific excellence and his influential role in the advancement of immunological research. Conclusion Francisco José Boix Giner is a well-qualified candidate for the Research for Best Researcher Award due to his extensive experience, significant contributions to immunology research, and strong academic background. To further strengthen his candidacy, focusing on increasing high-impact publications, expanding his research scope, and enhancing public engagement could be beneficial. Overall, his achievements and expertise make him a compelling candidate for the award. Publication Top Notes Killer-cell immunoglobulin-like receptor polymorphism is associated with COVID-19 outcome: Results of a pilot observational study Authors: Niño-Ramírez, J.E., Alcoceba, M., Gutiérrez-Zufiaurre, M.N., García-Sanz, R., Boix, F. Year: 2024 Journal: HLA CD8+CD69+ and CD8+CD95+ Mediate Early Post-Transplant Acute Tubular Injury in Kidney Recipients Authors: Boix, F., Jimenez-Coll, V., Legaz, I., Llorente, S., Muro, M. Year: 2023 Journal: Frontiers in Bioscience – Landmark Citations: 1 Monitoring of Serological, Cellular and Genomic Biomarkers in Transplantation, Computational Prediction Models and Role of Cell-Free DNA in Transplant Outcome Authors: Jimenez-Coll, V., Llorente, S., Boix, F., Legaz, I., Muro, M. Year: 2023 Journal: International Journal of Molecular Sciences Citations: 5 Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy Authors: Bailén, R., Alenda, R., Herruzo-Delgado, B., Anguita, J., Kwon, M. Year: 2023 Journal: Frontiers in Immunology Citations: 4 Identification of the novel HLA-A*23:01:01:27 allele in an acute myeloid patient and related donor Authors: Bastos, M., Alcoceba, M., Chillón, M.C., García-Sanz, R., Boix, F. Year: 2022 Journal: HLA Citations: 2 The age again in the eye of the COVID-19 storm: evidence-based decision making Authors: Martín, M.C., Jurado, A., Abad-Molina, C., Ocaña, E., Molina, J. Year: 2021 Journal: Immunity and Ageing Citations: 7 The novel HLA-DQB1*06:03:27 allele characterised by sequence-based typing in a European bone marrow donor Authors: Boix, F., Chillón, M.C., García-Sánchez, S., Alcoceba, M., Marín-Rubio, L.A. Year: 2021 Journal: HLA Citations: 2 Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome Authors: El Band, J.E.K., Llorente, S., Martinez-Garcia, P., Legaz, I., Muro, M. Year: 2021 Journal: Current Protein and Peptide Science Citations: 2 Allele and haplotype frequencies of HLA-A, -B, -C, -DRB1, -DQB1 and -DQA1 in Castile and Leon region from North West of Spain Authors: Boix, F., Marín-Rubio, L.A., Alcoceba, M., González, M., García-Sanz, R. Year: 2021 Journal: Human Immunology Citations: 1 Microrna expression changes in kidney transplant: Diagnostic efficacy of mir-150-5p as potential rejection biomarker, pilot study Authors: Alfaro, R., Legaz, I., Jimenez-Coll, V., Llorente, S., Muro, M. Year: 2021 Journal: Journal of Clinical Medicine Citations: 14
Francisco José Boix Giner has accumulated extensive experience in immunology across several prestigious institutions. He currently serves as a Specialist in Immunology at the Centro de Transfusión de la Comunidad Valenciana, where he has been employed since November 2021. Previously, Boix held similar roles at the Hospital Universitario de Salamanca from June 2018 to November 2021, the National Health Service Blood and Transplant, and the Anthony Nolan Foundation in the UK, from 2013 to 2018. His career began at the Hospital Universitario Virgen de La Arrixaca, where he completed his residency in immunology. Boix’s work has involved leading and contributing to significant research projects, including genomic characterization of leukemia and studies on COVID-19 immunogenetics. His professional journey reflects a robust expertise in both clinical and research settings within the field of immunology. Research Interest Francisco José Boix Giner’s research interests center around immunology, with a particular focus on the genetic and molecular mechanisms underlying immune responses and transplant outcomes. His work includes characterizing genetic variations associated with immune system functions, such as the role of HLA and KIR genes in disease susceptibility and treatment responses. He has been involved in projects studying the impact of genetic markers on the resistance and relapse of leukemia, as well as the immunogenetic factors influencing COVID-19 prognosis. His research also extends to exploring biomarkers for assessing individual responses to immunosuppressive treatments in organ transplant patients. Boix Giner’s contributions aim to enhance the understanding of immune system interactions, improve diagnostic and therapeutic strategies, and advance personalized medicine in immunology and transplant science. Research Skills Francisco José Boix Giner possesses extensive research skills in the field of immunology and biomedicine. His expertise spans across various critical areas, including the characterization of genomic mechanisms in high-risk leukemia, the impact of HLA system on SARS-CoV-2 infections, and the identification of immune genetic variations in COVID-19 patients. Boix Giner has a proven track record in coordinating and leading significant research projects, such as those focused on biomarkers for preeclampsia and uterine growth restriction, as well as haplotypic characterization in leukemia patients. His proficiency in advanced techniques, including next-generation sequencing (NGS) and single-cell analysis, is complemented by his ability to secure and manage substantial research funding. His role in high-impact projects and collaborations with esteemed institutions highlights his skill in translating complex scientific data into actionable insights, furthering advancements in immunological research and patient care. Award and Recognition Francisco José Boix Giner, an esteemed immunologist, has garnered notable recognition in his field through a series of distinguished awards and accolades. He has been acknowledged for his significant contributions to the field of immunology, particularly in genomics and biomarker research. Boix Giner’s exceptional work has been recognized with multiple awards, including those for his innovative research on immune responses and transplantation. His research on the characterization of genomic mechanisms in leukemia and the validation of biomarkers in transplantation has earned him commendations from various institutions. In addition, he has received accolades for his leadership in high-impact research projects and his contributions to advancing understanding in immunogenetics and biomedicine. Boix Giner’s accolades underscore his commitment to scientific excellence and his influential role in the advancement of immunological research. Conclusion Francisco José Boix Giner is a well-qualified candidate for the Research for Best Researcher Award due to his extensive experience, significant contributions to immunology research, and strong academic background. To further strengthen his candidacy, focusing on increasing high-impact publications, expanding his research scope, and enhancing public engagement could be beneficial. Overall, his achievements and expertise make him a compelling candidate for the award. Publication Top Notes Killer-cell immunoglobulin-like receptor polymorphism is associated with COVID-19 outcome: Results of a pilot observational study Authors: Niño-Ramírez, J.E., Alcoceba, M., Gutiérrez-Zufiaurre, M.N., García-Sanz, R., Boix, F. Year: 2024 Journal: HLA CD8+CD69+ and CD8+CD95+ Mediate Early Post-Transplant Acute Tubular Injury in Kidney Recipients Authors: Boix, F., Jimenez-Coll, V., Legaz, I., Llorente, S., Muro, M. Year: 2023 Journal: Frontiers in Bioscience – Landmark Citations: 1 Monitoring of Serological, Cellular and Genomic Biomarkers in Transplantation, Computational Prediction Models and Role of Cell-Free DNA in Transplant Outcome Authors: Jimenez-Coll, V., Llorente, S., Boix, F., Legaz, I., Muro, M. Year: 2023 Journal: International Journal of Molecular Sciences Citations: 5 Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy Authors: Bailén, R., Alenda, R., Herruzo-Delgado, B., Anguita, J., Kwon, M. Year: 2023 Journal: Frontiers in Immunology Citations: 4 Identification of the novel HLA-A*23:01:01:27 allele in an acute myeloid patient and related donor Authors: Bastos, M., Alcoceba, M., Chillón, M.C., García-Sanz, R., Boix, F. Year: 2022 Journal: HLA Citations: 2 The age again in the eye of the COVID-19 storm: evidence-based decision making Authors: Martín, M.C., Jurado, A., Abad-Molina, C., Ocaña, E., Molina, J. Year: 2021 Journal: Immunity and Ageing Citations: 7 The novel HLA-DQB1*06:03:27 allele characterised by sequence-based typing in a European bone marrow donor Authors: Boix, F., Chillón, M.C., García-Sánchez, S., Alcoceba, M., Marín-Rubio, L.A. Year: 2021 Journal: HLA Citations: 2 Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome Authors: El Band, J.E.K., Llorente, S., Martinez-Garcia, P., Legaz, I., Muro, M. Year: 2021 Journal: Current Protein and Peptide Science Citations: 2 Allele and haplotype frequencies of HLA-A, -B, -C, -DRB1, -DQB1 and -DQA1 in Castile and Leon region from North West of Spain Authors: Boix, F., Marín-Rubio, L.A., Alcoceba, M., González, M., García-Sanz, R. Year: 2021 Journal: Human Immunology Citations: 1 Microrna expression changes in kidney transplant: Diagnostic efficacy of mir-150-5p as potential rejection biomarker, pilot study Authors: Alfaro, R., Legaz, I., Jimenez-Coll, V., Llorente, S., Muro, M. Year: 2021 Journal: Journal of Clinical Medicine Citations: 14
Killer-cell immunoglobulin-like receptor polymorphism is associated with COVID-19 outcome: Results of a pilot observational study Authors: Niño-Ramírez, J.E., Alcoceba, M., Gutiérrez-Zufiaurre, M.N., García-Sanz, R., Boix, F. Year: 2024 Journal: HLA CD8+CD69+ and CD8+CD95+ Mediate Early Post-Transplant Acute Tubular Injury in Kidney Recipients Authors: Boix, F., Jimenez-Coll, V., Legaz, I., Llorente, S., Muro, M. Year: 2023 Journal: Frontiers in Bioscience – Landmark Citations: 1 Monitoring of Serological, Cellular and Genomic Biomarkers in Transplantation, Computational Prediction Models and Role of Cell-Free DNA in Transplant Outcome Authors: Jimenez-Coll, V., Llorente, S., Boix, F., Legaz, I., Muro, M. Year: 2023 Journal: International Journal of Molecular Sciences Citations: 5 Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy Authors: Bailén, R., Alenda, R., Herruzo-Delgado, B., Anguita, J., Kwon, M. Year: 2023 Journal: Frontiers in Immunology Citations: 4 Identification of the novel HLA-A*23:01:01:27 allele in an acute myeloid patient and related donor Authors: Bastos, M., Alcoceba, M., Chillón, M.C., García-Sanz, R., Boix, F. Year: 2022 Journal: HLA Citations: 2 The age again in the eye of the COVID-19 storm: evidence-based decision making Authors: Martín, M.C., Jurado, A., Abad-Molina, C., Ocaña, E., Molina, J. Year: 2021 Journal: Immunity and Ageing Citations: 7 The novel HLA-DQB1*06:03:27 allele characterised by sequence-based typing in a European bone marrow donor Authors: Boix, F., Chillón, M.C., García-Sánchez, S., Alcoceba, M., Marín-Rubio, L.A. Year: 2021 Journal: HLA Citations: 2 Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome Authors: El Band, J.E.K., Llorente, S., Martinez-Garcia, P., Legaz, I., Muro, M. Year: 2021 Journal: Current Protein and Peptide Science Citations: 2 Allele and haplotype frequencies of HLA-A, -B, -C, -DRB1, -DQB1 and -DQA1 in Castile and Leon region from North West of Spain Authors: Boix, F., Marín-Rubio, L.A., Alcoceba, M., González, M., García-Sanz, R. Year: 2021 Journal: Human Immunology Citations: 1 Microrna expression changes in kidney transplant: Diagnostic efficacy of mir-150-5p as potential rejection biomarker, pilot study Authors: Alfaro, R., Legaz, I., Jimenez-Coll, V., Llorente, S., Muro, M. Year: 2021 Journal: Journal of Clinical Medicine Citations: 14
Taher Azimi | Microbioligy | Best Researcher Award Posted on 13/04/202413/04/2024 by ScienceFather Assist Prof Dr. Taher Azimi | Microbioligy | Best Researcher Award Faculty member at Shiraz University of Medical Sciences, Iran.